RBI
DGX icon

Raiffeisen Bank International’s Quest Diagnostics DGX Stock Holding History

Raiffeisen Bank International’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$50.8K Buy
239
+148
+163% +$29K ﹤0.01% 589
2026
Q1 		$17.9K Hold
91
– – ﹤0.01% 659
2025
Q4 		$16K Hold
91
– – ﹤0.01% 653
2025
Q3 		$17.2K Sell
91
-2,492
-96% -$442K ﹤0.01% 642
2025
Q2 		$461K Sell
2,583
-1,003
-28% -$174K 0.01% 381
2025
Q1 		$600K Sell
3,586
-32
-0.9% -$5.26K 0.01% 347
2024
Q4 		$546K Buy
+3,618
New +$563K 0.01% 344

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Raiffeisen Bank International's DGX Position: Q2 2026 in Review

Raiffeisen Bank International increased its Quest Diagnostics (DGX) stake by 163% in Q2 2026, buying an estimated $29K and bringing the position to 239 shares worth $50.8K. The position accounts for ﹤0.01% of the portfolio, ranked #589.

Raiffeisen Bank International first reported a position in DGX in Q4 2024 and has held it in 7 quarters since. The position peaked at $600K in Q1 2025. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Raiffeisen Bank International held 239 shares of Quest Diagnostics worth $50.8K as of Q2 2026.
  • Raiffeisen Bank International bought 148 Quest Diagnostics shares in Q2 2026, an estimated $29K.
  • Quest Diagnostics made up ﹤0.01% of Raiffeisen Bank International's portfolio in Q2 2026, its #589 holding.
  • Raiffeisen Bank International first reported a position in Quest Diagnostics in Q4 2024 and has held it in 7 quarters since.
  • Raiffeisen Bank International's Quest Diagnostics position peaked at $600K in Q1 2025.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Raiffeisen Bank International's 13F filing for Q2 2026, filed 3 Aug 2026.